Acer Therapeutics Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Acer Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • Acer Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $13.1M, a 17.4% increase year-over-year.
  • Acer Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $20M, a 181% increase from 2021.
  • Acer Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $7.14M, a 33.4% decline from 2020.
  • Acer Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $10.7M, a 11520% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $20M +$12.9M +181% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $7.14M -$3.58M -33.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $10.7M +$10.6M +11520% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $92.3K -$42.6M -99.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $42.7M +$15.8M +58.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 $26.9M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2013 $28.4M +$24.5M +619% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-27
2012 $3.96M -$4.63M -53.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-27
2011 $8.58M +$8.54M +20182% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-29
2010 $42.3K Jan 1, 2010 Dec 31, 2010 10-K 2012-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.